A comparison between octreotide-LAR and lanreotide-SR in the chronic treatment of acromegaly

Abstract

These preliminary results show that the once-monthly OC-LAR administration schedule proved more efficacious than LSR given every 7-21 days, in a greater number of acromegalic patients.